News of a setback on a coronavirus vaccine candidate and reports of the
first COVID-19 reinfection in the United States are sapping investor
sentiment, while the official start of earnings season, the unofficial
start of the US holiday shopping season, and Apple’s iPhone launch event
are all moving markets.
Shares of Johnson & Johnson were down more than two percent
minutes into the trading session after the pharmaceutical giant said it
had paused clinical trials of its coronavirus vaccine candidate due to
an “unexplained illness” in a study participant.
Last month, AstraZeneca halted a late-stage trial of a COVID-19 vaccine candidate after a participant fell ill.
The news follows in the wake of more documented evidence that sheds doubt on whether herd immunity to COVID-19 is possible.
Read more at:
COVID-19 vaccine setback weighs on Wall Street | US & Canada News | Al Jazeera
